Computational design of drug candidates for influenza A virus subtype H1N1 by inhibiting the viral neuraminidase-1 enzyme
It is critical to seek potential alternative treatments for H1N1 infections by inhibiting neuraminidase-1 enzyme. One of the viable options for inhibiting the activity of neuraminidase- 1 is peptide drug design. In order to increase peptide stability, cyclization is necessary to prevent its digestio...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2014-06-01
|
Series: | Acta Pharmaceutica |
Subjects: | |
Online Access: | http://www.degruyter.com/view/j/acph.2014.64.issue-2/acph-2014-0015/acph-2014-0015.xml?format=INT |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|